Author: usaeverydaylife

The U.S. Capitol building, weeks into the continuing U.S. government shutdown, in Washington on Oct. 27, 2025. Kylie Cooper | ReutersBusinesses that contract with the federal government lost $12 billion in the first four weeks of the government shutdown, according to a report from the U.S. Chamber of Commerce released Thursday.The report, which the Chamber is sending to members of Congress, shows that 65,500 small businesses across the United States are losing around $3 billion per week from the shutdown.Companies affected by the shutdown include providers of high-tech machinery, office supplies, and landscaping services, according to the report, which was…

Read More

San Francisco Mayor Daniel Lurie speaks during a press conference at San Francisco City Hall on Oct. 23, 2025 in San Francisco, California.Justin Sullivan | Getty ImagesSan Francisco Mayor Daniel Lurie, who was recently thrust into a national debate about the safety of big cities, told CNBC on Thursday that he feels “pressure every day” to continue improving conditions for residents. Last week, President Donald Trump reversed plans for a “federal surge” in San Francisco. The potential National Guard deployment hit the headlines when Salesforce CEO Marc Benioff told the New York Times that he’d support Trump’s call for federal troops to be…

Read More

Mateusz Slodkowski | SOPA Images | Lightrocket | Getty ImagesNetflix announced a 10-for-1 stock split Thursday, a move that changes nothing fundamentally about the company, but could make the pricey individual shares more accessible to the retail investor.Existing shareholders as of Nov. 10 will receive nine additional shares for each one they hold. They’ll get that allotment on Nov. 14, and the stock will begin trading at the new post-split price on Monday, Nov. 17.Netflix, the streaming leader whose shares have boomed over the last three years to above $1,000 apiece, said it was making the change to “reset the…

Read More

Thomas Fuller | SOPA Images | Lightrocket | Getty ImagesCoinbase shares ticked up 2% Thursday as the crypto exchange posted strong financial results for the third quarter that exceeded Wall Street’s expectations.In the quarter ended Sept. 30, Coinbase net income rose to $432.6 million, or $1.50 per share, from $75.5 million, or 28 cents per share, a year ago. Earnings topped the consensus estimate of $1.10 reported by LSEG.Revenue rose to $1.87 billion from $1.21 billion in the same quarter last year, coming in above analysts’ expectations of $1.8 billion. Revenue tied to transactions came in 37% higher quarter-over-quarter at $1…

Read More

Stocks including Wingstop , Arista Networks and Shopify that are due to report next week have a track record of beating Wall Street’s earnings estimates and outperforming on the next trading day. The third-quarter earnings season is barely slowing down, with 129 companies in the S & P 500 — or just over a quarter of the index — on the docket to post results next week. Chipmakers AMD , Qualcomm and Arm Holdings will headline the week, but there will also be a notable showing from restaurants such as McDonald’s and other consumer-facing businesses. Stocks often enjoy a post-earnings…

Read More

Reddit CEO Steve Huffman stands on the floor of the New York Stock Exchange (NYSE) after ringing a bell on the floor setting the share price at $47 in its initial public offering (IPO) on March 21, 2024 in New York City.Spencer Platt | Getty ImagesReddit reported third-quarter earnings on Thursday in which the company beat on the top and bottom and provided strong guidance.Shares were up more than 5% in after-hours trading on Thursday.Here’s how the company did compared with LSEG estimates:Earnings per share: 80 cents vs. 51 cents expectedRevenue: $585 million vs. $546 million expectedReddit’s sales jumped 68% year-over-year in…

Read More

FILE PHOTO: Britain’s Prince Andrew leaves Westminster Abbey following the coronation ceremony of Britain’s King Charles and Queen Camilla, in London, Britain May 6, 2023. Toby Melville | ReutersBritain’s King Charles has stripped his younger brother Andrew of his title of prince and forced him out of his home by Windsor Castle, Buckingham Palace said on Thursday, punishing him over his ties to the late sex offender Jeffrey Epstein.Andrew, 65, the younger brother of Charles and second son of the late Queen Elizabeth, has come under mounting pressure over his behavior and ties to Epstein and earlier this month he…

Read More

Apple reported fiscal-fourth quarter earnings on Thursday that beat analyst expectations, and provided a strong forecast for the company’s December quarter.  Shares of the iPhone maker were flat in extended trading.Here’s how the iPhone maker did versus LSEG consensus estimates for the quarter ending September 27: EPS: $1.85 vs. $1.77 estimated  Revenue: $102.47 billion vs. $102.24 billion estimated  Here’s how Apple’s main business lines did versus consensus estimates:  iPhone revenue: $49.03 billion vs. $50.19 billion estimated  Mac revenue: $8.73 billion vs. $8.59 billion estimated  iPad revenue: $6.95 billion vs. $6.98 billion estimated  Other Products revenue: $9.01 billion vs. $8.49 billion estimated  Services revenue: $28.75 billion vs. $28.17 billion estimated…

Read More

It’s been a stellar few months for shares of San Francisco-based biotech company Rigel Pharmaceuticals, which has approved treatments for rheumatology and oncology — as well as potential new drugs in the pipeline.The stock has jumped about 50% in just the last three months, earning it a spot on CNBC’s list of top performing stocks of companies based in the City by the Bay. To find the stocks, CNBC screened for names based in the area that had market caps above $500 million. We then screened for the top performers over the last three months via FactSet.”We have a business…

Read More

Wall Street is optimistic that Olema Pharmaceutical could be developing the next major breakthrough breast cancer treatment.Earlier this month, the company announced promising clinical data for its lead candidate palazestrant, an oral medication that is being evaluated in several trials for estrogen receptor-positive, or ER+, breast cancer.Shares of the clinical-stage biopharmaceutical company are up about 50% this year, and more than 70% over the past three months. Analysts polled by FactSet see plenty of upside ahead for Olema. Their average price target of $23.71 per share suggests the stock could skyrocket about 164% from its last closing price. Olema was included…

Read More